InvestorsHub Logo

Notademoc

06/12/20 6:06 AM

#279636 RE: tucaman #279635

Good numbers

JJPow

06/12/20 6:47 AM

#279642 RE: tucaman #279635

Vascpea #'s are great, but Generic Lovaza outperforming V? WTF?

Bluensleepy

06/12/20 7:05 AM

#279645 RE: tucaman #279635

Thank you!

circuitcity

06/12/20 7:29 AM

#279652 RE: tucaman #279635

Thanks a lot for the report.

Hope to see V break 100k soon,has been hovering around 80+k too long

Invest83838

06/12/20 7:30 AM

#279654 RE: tucaman #279635

Amarin Not Making Headway Against Generic Lovaza

Thanks to uninformed or corrupt insurance companies and doctors

Once Generic Vascepa is available,

forget about the USA (and I think possibly worldwide) revenue for non-generic Vascepa

Without an appeal reversal, Judge Du Du has killed Amarin

unless Amarin sells generic Vascepa at least in USA and possibly worldwide

and ensures other generic companies do not have raw material supply



Hondo1021

06/12/20 10:01 AM

#279693 RE: tucaman #279635

Thanks tucaman. Nice numbers. ATH for refills. #3ATH for total scripts. The salespeople are doing their jobs.

It was a holiday rebound week, but I'll still take it.

Restingzebra

06/12/20 12:51 PM

#279758 RE: tucaman #279635

Thank you T. As always greatly appreciate your efforts.

ralphey

06/12/20 3:27 PM

#279794 RE: tucaman #279635

A generic beating out vascepa -- who would have ever thought ....

tucaman

06/19/20 9:14 AM

#281445 RE: tucaman #279635

Scripts for week ending 06/12/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.


Vascepa
TRx: 88'463 (+1.21%)
NRx: 40'090 (+2.66%)

Generic Lovaza
TRx: 63'667 (-0.39%)
NRx: 30'583 (+3.09%)